Arletta Pharma Solutions
PrivateLast Round
Seed
Mar 29, 2022
Total Funding Raised
$8.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Arletta Pharma Solutions is a pharmaceutical company developing innovative therapies for women diagnosed with Female Sexual Interest/Arousal Disorder (FSIAD).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arletta Pharma Solutions Comparables
Compare Arletta Pharma Solutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| S1 Biopharma, Inc. | 81% | |
| Covis Pharma | 74% | |
| JASTLabs Corp | 74% | |
Arletta Pharma Solutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 29, 2022 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors increased 113% MoM.
- Jan 28, 2025
Manuel Voll appointed as Chairman of the Supervisory Board.
Arletta Pharma Solutions Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Arletta Pharma Solutions's valuation, stock price, and market status.